Nano-X gets clearance for ARC imaging system, says Cantor Fitzgerald

Cantor Fitzgerald reiterates an Overweight rating and $21 price target on Nano-X Imaging. The company announced that it has received FDA 510(k) clearance for Nanox.ARC, including Nanox.CLOUD, and Nano-X will now able to market the system to healthcare facilities via its pay- per-scan business model in the U.S., the analyst tells investors in a research note. The firm believes the Nanox.ARC System is a disruptive technology that will be adopted quickly, particularly in developing countries.